tiprankstipranks
Advertisement
Advertisement

DE:UG2 Stock Latest News

AngioDynamics: Strong Med Tech Growth Outlook Supports Buy Rating and Maintained $20 Price Target
RatingsAngioDynamics: Strong Med Tech Growth Outlook Supports Buy Rating and Maintained $20 Price Target
11d ago
ANGO
AngioDynamics price target raised to $19 from $16 at H.C. Wainwright
PremiumThe Fly
AngioDynamics price target raised to $19 from $16 at H.C. Wainwright
1M ago
ANGO
AngioDynamics price target raised to $20 from $16 at Canaccord
PremiumThe Fly
AngioDynamics price target raised to $20 from $16 at Canaccord
1M ago
ANGO
AngioDynamics posts record Q4 and fiscal 2026 results
PremiumCompany Announcements
AngioDynamics posts record Q4 and fiscal 2026 results
1M ago
8K
ANGO
AngioDynamics Earnings Call Highlights Med Tech Surge
PremiumCompany Announcements
AngioDynamics Earnings Call Highlights Med Tech Surge
1M ago
ANGO
ANGO Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsANGO Upcoming Earnings Report: What to Expect?
1M ago
ANGO
AngioDynamics receives FDA IDE approval for RELIEF feasibility study
Premium
The Fly
AngioDynamics receives FDA IDE approval for RELIEF feasibility study
2M ago
ANGO
AngioDynamics announces two-year PRESERVE trial data
Premium
The Fly
AngioDynamics announces two-year PRESERVE trial data
3M ago
ANGO
AngioDynamics Files Patent Suit to Protect Thrombectomy Technology
PremiumCompany Announcements
AngioDynamics Files Patent Suit to Protect Thrombectomy Technology
4M ago
8K
ANGO
AngioDynamics initiated with a Buy at Freedom Broker
PremiumThe Fly
AngioDynamics initiated with a Buy at Freedom Broker
5M ago
ANGO
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
PremiumRatings
AngioDynamics: Improving Fundamentals and Strategic Transition Support Buy Rating and Higher Price Target
5M ago
ANGO
AngioDynamics price target lowered to $16 from $18 at Canaccord
PremiumThe Fly
AngioDynamics price target lowered to $16 from $18 at Canaccord
5M ago
ANGO
AngioDynamics Earnings Call Highlights Med Tech Momentum
PremiumCompany AnnouncementsAngioDynamics Earnings Call Highlights Med Tech Momentum
5M ago
ANGO
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
Premium
The Fly
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
5M ago
F
BP
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance
Premium
Company Announcements
AngioDynamics Posts Strong Q3 Results, Raises 2026 Guidance
5M ago
8K
ANGO
AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
PremiumThe Fly
AngioDynamics reports Q3 adjusted EPS (7c), consensus (11c)
5M ago
ANGO
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
PremiumThe Fly
AngioDynamics narrow FY26 EPS view to (30c)-(23c) from (33c)-(23c)
5M ago
ANGO
AngioDynamics announces CEO transition and leadership retention plan
PremiumCompany Announcements
AngioDynamics announces CEO transition and leadership retention plan
7M ago
8K
ANGO
AngioDynamics Highlights Growth Strategy at J.P. Morgan Conference
PremiumCompany Announcements
AngioDynamics Highlights Growth Strategy at J.P. Morgan Conference
7M ago
8K
ANGO
AngioDynamics: Operational Outperformance, Raised FY2026 Outlook, and Advancing Clinical Pipeline Support Buy Rating and $16 Target
PremiumRatingsAngioDynamics: Operational Outperformance, Raised FY2026 Outlook, and Advancing Clinical Pipeline Support Buy Rating and $16 Target
8M ago
ANGO
AngioDynamics Earnings Call Highlights Med Tech Momentum
Premium
Company Announcements
AngioDynamics Earnings Call Highlights Med Tech Momentum
8M ago
ANGO
Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix
Premium
The Fly
Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix
8M ago
E
ET

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >